SCHEMBL2228798

SCHEMBL2228798

Cc1ccc(N2CCN(C)CC2)cc1CO

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 1/20 0.51
KMT2A Q03164 3/20 0.48
KDM4E B2RXH2 4/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTR3A P46098 1/20 0.47
GAA P10253 3/20 0.46
MAPT P10636 2/20 0.46
PTK2B Q14289 2/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
RECQL P46063 1/20 0.46
MEN1 O00255 1/20 0.45
GLA P06280 1/20 0.45
ADRA2C P18825 2/20 0.45
ALDH1A1 P00352 2/20 0.44
GFER P55789 1/20 0.44
ESR2 Q92731 1/20 0.44
SIRT6 Q8N6T7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14922272 0.86 CHKA (0.54) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL30760572 0.83 KDM4E (0.50) KMT2AKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL10061499 0.82 KDM4E (0.61) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL29126327 0.82 CHKA (0.50) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL11245265 0.79 DRD4 (0.57) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL14922279 0.79 CHKA (0.50) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL8320347 0.78 ADRB1 (0.63) KMT2AKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL27313475 0.78 KDM4E (0.40) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL1599368 0.77 SIRT6 (0.58) CHKAKMT2AKDM4ENPC1RAB9A
SCHEMBL22634636 0.76 SIRT6 (0.68) MAPTMAPK1ALDH1A1SIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519517-A2 TYPE II RAF KINASE INHIBITORS Dana-Farber Cancer Institute, Inc. (US) 2012-11-07 EP disclosed
WO-2011090738-A2 TYPE II RAF KINASE INHIBITORS DANA-FARBER CANCER INSTITUTE, INC. (US) 2011-07-28 WO disclosed